Prelude Therapeutics, Lilly to Test Experimental Drug in Phase 1 Trial

Prelude Therapeutics announced a clinical trial collaboration and supply agreement with Eli Lilly to evaluate PRT13722 alongside two Lilly medicines for breast cancer.